Guggenheim Capital LLC Ptc Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 25,147 shares of PTCT stock, worth $986,516. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,147

Previous 24,413 3.01%

Holding current value

$986,516

Previous $746,000 24.93%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$30.39 - $37.66 $22,306 - $27,642	734 Added 3.01%	25,147 $932,000
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $138,980 - $225,835	-5,629 Reduced 18.74%	24,413 $746,000
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $38,084 - $50,385	-1,577 Reduced 4.99%	30,042 $873,000
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $95,499 - $155,220	5,285 Added 20.07%	31,619 $871,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $40,338 - $75,582	1,800 Added 7.34%	26,334 $590,000
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $52,439 - $76,711	1,298 Added 5.59%	24,534 $997,000
Q1 2023 May 10, 2023	BUY	$38.16 - $48.86 $886,685 - $1.14 Million	23,236 New	23,236 $1.13 Million
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $1.28 Million - $1.52 Million	-36,280 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $9,400 - $11,363	-254 Reduced 0.7%	36,280 $1.35 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $114,495 - $148,949	3,017 Added 9.0%	36,534 $1.54 Million
Q1 2021 May 13, 2021	SELL	$46.8 - $68.92 $7,020 - $10,338	-150 Reduced 0.45%	33,517 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $498,736 - $703,388	-10,399 Reduced 23.6%	33,667 $2.06 Million
Q3 2020 Nov 13, 2020	SELL	$45.41 - $57.07 $349,202 - $438,868	-7,690 Reduced 14.86%	44,066 $2.06 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $230,717 - $298,046	5,421 Added 11.7%	51,756 $2.63 Million
Q1 2020 Jun 02, 2020	SELL	$32.37 - $59.36 $294,049 - $539,226	-9,084 Reduced 16.39%	46,335 $2.07 Million
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $49,328 - $76,657	-1,531 Reduced 2.69%	55,419 $2.66 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $1,792 - $2,553	53 Added 0.09%	56,950 $1.93 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $524,570 - $666,450	-14,810 Reduced 20.65%	56,897 $2.56 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $208,006 - $292,423	7,405 Added 11.52%	71,707 $2.7 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $1.92 Million - $2.99 Million	64,302 New	64,302 $2.21 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $1.68 Million - $3.13 Million	-65,289 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$17.46 - $32.59 $377,467 - $704,563	-21,619 Reduced 24.88%	65,289 $1.77 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $1.32 Million - $1.82 Million	86,908	86,908 $1.45 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Ptc Therapeutics, Inc. Transaction History